Graeme Smith

3.0k total citations
61 papers, 2.1k citations indexed

About

Graeme Smith is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Graeme Smith has authored 61 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 26 papers in Genetics and 14 papers in Oncology. Recurrent topics in Graeme Smith's work include Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Lymphoma Diagnosis and Treatment (12 papers). Graeme Smith is often cited by papers focused on Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Lymphoma Diagnosis and Treatment (12 papers). Graeme Smith collaborates with scholars based in United Kingdom, United States and France. Graeme Smith's co-authors include Judith S. Weis, Peddrick Weis, Tong Zhou, Gareth J. Morgan, Andy C. Rawstron, J. A. Child, Roger G. Owen, Paul Evans, Andrew Jack and Ayalew Tefferi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Graeme Smith

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graeme Smith United Kingdom	21	967	632	585	403	387	61	2.1k
Stephanie G. Willis United States	18	1.1k 1.1×	871 1.4×	163 0.3×	112 0.3×	397 1.0×	32	1.8k
Gerhard Held Germany	32	540 0.6×	515 0.8×	1.3k 2.2×	1.1k 2.6×	588 1.5×	145	3.8k
Tor Knutsen Norway	32	350 0.4×	321 0.5×	697 1.2×	326 0.8×	1.0k 2.7×	97	3.3k
Michael R. Cooper United States	29	412 0.4×	271 0.4×	1.3k 2.2×	125 0.3×	1.3k 3.3×	104	3.8k
Noboru Yamagata Japan	21	404 0.4×	146 0.2×	303 0.5×	82 0.2×	329 0.9×	122	1.8k
Thomas Schroeder Germany	30	1.6k 1.7×	566 0.9×	358 0.6×	63 0.2×	596 1.5×	143	2.8k
M Seto Japan	26	542 0.6×	653 1.0×	841 1.4×	931 2.3×	1.7k 4.3×	87	3.2k
Younghun Jung South Korea	25	692 0.7×	423 0.7×	1.1k 2.0×	45 0.1×	840 2.2×	71	3.0k
Ann H. Williams United States	16	208 0.2×	109 0.2×	374 0.6×	108 0.3×	423 1.1×	30	1.6k
J. Thiele Germany	26	648 0.7×	683 1.1×	91 0.2×	62 0.2×	721 1.9×	121	2.4k

Countries citing papers authored by Graeme Smith

Since Specialization

Citations

This map shows the geographic impact of Graeme Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Smith more than expected).

Fields of papers citing papers by Graeme Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Smith. The network helps show where Graeme Smith may publish in the future.

Co-authorship network of co-authors of Graeme Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Smith. A scholar is included among the top collaborators of Graeme Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Smith. Graeme Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, A. G., Dan Painter, Debra Howell, et al.. (2014). Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort. BMJ Open. 4(1). e004266–e004266. 42 indexed citations

Pettengell, Ruth, Norbert Schmitz, Christian Gisselbrecht, et al.. (2013). Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology. 31(13). 1624–1630. 77 indexed citations

Cook, Gordon, Graeme Smith, Keiren Kirkland, et al.. (2010). Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 16(10). 1419–1427. 69 indexed citations

Rawstron, Andy C., Elena Jones, Carol Reid, et al.. (2007). Outreach monitoring service for patients with indolent B‐cell and plasma cell disorders: a UK experience. British Journal of Haematology. 139(5). 845–848. 12 indexed citations

Dasgupta, Ranjit, Simon Rule, Peter Johnson, et al.. (2006). Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect. Bone Marrow Transplantation. 37(5). 455–461. 16 indexed citations

Moreton, Paul, Gareth J. Morgan, D. Gilson, et al.. (2004). The development of targeted chemotherapy for CNS lymphoma?a pilot study of the IDARAM regimen. Cancer Chemotherapy and Pharmacology. 53(4). 324–328. 14 indexed citations

Pratt, Guy, Andy C. Rawstron, Roderick J. Johnson, et al.. (2001). Analysis of CD34⁺ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34⁺ cell dose, but steady state levels do not correlate with bone marrow reserve. British Journal of Haematology. 114(4). 937–943. 18 indexed citations

Jackson, Graham, P R Taylor, Graeme Smith, et al.. (2001). A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. British Journal of Haematology. 112(1). 127–137. 99 indexed citations

Pratt, Guy, James A. L. Fenton, Faith E. Davies, et al.. (2001). Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma. British Journal of Haematology. 112(2). 388–391. 6 indexed citations

10.

Davies, Faith E., Peter Forsyth, Andy C. Rawstron, et al.. (2001). The impact of attaining a minimal disease state after high‐dose melphalan and autologous transplantation for multiple myeloma. British Journal of Haematology. 112(3). 814–819. 84 indexed citations

11.

Pratt, Guy, Marc E. Wiles, Andy C. Rawstron, et al.. (1998). Liposomal daunorubicin:in vitro andin vivo efficacy in multiple myeloma. Hematological Oncology. 16(2). 47–55. 17 indexed citations

12.

Rawstron, Andy C., Roger G. Owen, Faith E. Davies, et al.. (1997). Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Haematology. 97(1). 46–55. 151 indexed citations

13.

Linch, David C., Donald Milligan, D.A. Winfield, et al.. (1997). G‐CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. British Journal of Haematology. 99(4). 933–938. 53 indexed citations

14.

Johnson, Roderick J. & Graeme Smith. (1997). Mobilisation and Reinfusion of Philadelphia Negative Peripheral Blood Mononuclear Cells in Chronic Myeloid Leukaemia with Hydroxyurea and G-CSF. Leukemia & lymphoma. 27(5-6). 401–415. 5 indexed citations

15.

Smith, Graeme, J. A. Child, M.H. Cullen, et al.. (1996). A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (r-MetHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). Hematological Oncology. 14(4). 193–201. 8 indexed citations

16.

Johnson, Roderick J., Roger G. Owen, J. A. Child, et al.. (1996). MOBILIZATION OF PHILADELPHIA‐NEGATIVE PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC MYELOID LEUKAEMIA USING HYDROXYUREA AND G‐CSF (FILGRASTIM). British Journal of Haematology. 93(4). 863–868. 20 indexed citations

17.

Owen, Roger G., A. P. Haynes, Paul Evans, et al.. (1996). Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection. Molecular Pathology. 49(2). M112–M117. 3 indexed citations

18.

Owen, Roger G., Russell Patmore, Graeme Smith, & D. L. Barnard. (1995). Cytomegalovirus‐induced T‐cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. British Journal of Haematology. 89(1). 196–198. 24 indexed citations

19.

Smith, Graeme, D. Hamish Wright, J. A. Child, et al.. (1992). A pilot study of chlophepp‐B—A weekly regimen for patients with untreated advanced or recurrent hodgkin's disease. Hematological Oncology. 10(6). 311–318. 2 indexed citations

20.

Hughes, Richard T., D W Milligan, Graeme Smith, M. J. Leyland, & E. C. Gordon‐Smith. (1988). Case Report: A SECOND BONE MARROW TRANSPLANT FOR ACUTE MYELOID LEUKAEMIA AFTER TRANSPLANTATION FOR APLASTIC ANAEMIA. British Journal of Haematology. 68(3). 391–391. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact